Sept 25 (Reuters) – The US Food and Drug Administration has approved Mirum Pharmaceuticals’ drug to treat a rare bone disorder, the regulator said on Friday.
(Reporting by Kunal Das and Christy Santhosh in Bengaluru; Editing by Jonathan Ananda)
